Inhibition in cancer treatment involves targeting specific molecules or pathways that promote tumor growth and survival. By inhibiting these targets, therapies can effectively slow down or stop cancer progression, enhance apoptosis, and reduce angiogenesis, thereby improving treatment efficacy and patient outcomes while potentially minimizing damage to healthy cells.